作者：
Blagden, S. [1]
;
Hamilton, A. [2]
;
Mileshkin, L. [3]
;
Hall, M. [4]
;
Meniawy, T. [5]
;
Wong, S. [6]
;
Anandra, S. [7]
;
Buck, M. [8]
;
McAleer, D. [9]
;
Reedy, B. A. ;
Noble, R. B. ;
Smith, D. A. ;
Morris, S. R. ;
Gabra, H.
作者单位：
GlaxoSmithKline, GSK Alternat Discovery & Dev, Res Triangle Pk, NC USA
[1]
Western Hosp, Dept Oncol, Footscray, Vic, Australia
[2]
Imperial Coll Hammersmith Hosp Campus, Dept Med Oncol, London, England
[3]
GlaxoSmithKline, GSK Alternat Discovery & Dev, Upper Merion, PA USA
[4]
GlaxoSmithKline, GSK Clin Pharmacol Modelling & Simulat, Brentford, England
[5]
Sir Charles Gairdner Hosp, Dept Med Oncol, Perth, WA, Australia
[6]
Peter MacCallum Canc Ctr, Dept Canc Med, East Melbourne, Australia
[7]
Royal Womens Hosp, Dept Med Oncol, Parkville, Vic, Australia
[8]
Mt Vernon Canc Ctr, Dept Med Oncol, Northwood, Middx, England
[9]
发布时间
2020-08-22
换一批
![European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)](https://cdnimg.med.wanfangdata.com.cn/imgs/qkindeximg/N2007EPST0000700/N2007EPST0000700.jpg)
